PhaseV
PhaseV develops advanced AI/ML solutions to optimize clinical development. Their platform helps biopharma sponsors and CROs design and execute clinical trials more efficiently, analyze data to uncover treatment effects, and inform R&D decisions. PhaseV's platform has demonstrated a reduction in trial costs, enrollment size/duration, and increased the likelihood of trial success.
Funding Round: Series A
Funding Amount: $50M
Date: 13-May-2025
Investors: Accel, Insight Partners, Viola Ventures, EXOR, LionBird
Markets: AI, Biotech, Pharma
HQ: Boston, Massachusetts, United States
Founded: 2023
Website: https://phasevtrials.com/
LinkedIn: https://www.linkedin.com/company/phasevtrials
Crunchbase: https://www.crunchbase.com/organization/phasev
Leave a Comment
Comments
No comments yet.